SCHEMBL160878

SCHEMBL160878

Fc1ccccc1N=C=S

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
CYP3A4 P08684 2/20 0.52
HPGD P15428 2/20 0.52
ABCB11 O95342 1/20 0.52
NR3C1 P04150 1/20 0.52
CYP1A2 P05177 1/20 0.52
ADRA2A P08913 1/20 0.52
ADORA3 P0DMS8 1/20 0.52
ALOX15 P16050 1/20 0.52
ADRA2C P18825 1/20 0.52
MAOA P21397 1/20 0.52
DRD1 P21728 1/20 0.52
SLC6A4 P31645 1/20 0.52
HTR2B P41595 1/20 0.52
CCR2 P41597 1/20 0.52
HSD17B10 Q99714 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
MIF P14174 2/20 0.46
POLB P06746 1/20 0.43
APLNR P35414 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30298614 1.00 ALDH1A1 (0.52) ALDH1A1CYP3A4HPGDABCB11NR3C1
Pentachlorophenol SCHEMBL10685234 0.84 ALDH1A1 (0.40) ALDH1A1CYP3A4HPGDABCB11NR3C1
SCHEMBL2768046 0.82 ALDH1A1 (0.48) ALDH1A1CYP3A4HPGDABCB11NR3C1
SCHEMBL207554 0.82 ALDH1A1 (0.62) ALDH1A1CYP3A4HPGDABCB11NR3C1
SCHEMBL29374052 0.82 ALDH1A1 (0.62) ALDH1A1CYP3A4HPGDABCB11NR3C1
SCHEMBL8675112 0.80 ACHE (0.37) ALDH1A1CYP3A4HPGDABCB11NR3C1
SCHEMBL2769195 0.79 ALDH1A1 (0.46) ALDH1A1CYP3A4HPGDABCB11NR3C1
SCHEMBL7256052 0.79 ALDH1A1 (0.46) ALDH1A1CYP3A4HPGDABCB11NR3C1
SCHEMBL2770263 0.79 ALDH1A1 (0.46) ALDH1A1CYP3A4HPGDABCB11NR3C1
SCHEMBL93162 0.76 CYP3A4 (0.52) ALDH1A1CYP3A4HPGDALOX15TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 476 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12402638-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2025-09-02 US claimed
US-20250194617-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-06-19 US claimed
US-20250169514-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2025-05-29 US claimed
US-12232516-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2025-02-25 US claimed
US-12193465-B2 Materials and methods for extending shelf-life of foods JP LABORATORIES, INC. (US) 2025-01-14 US claimed
CN-118738556-A Electrolyte and lithium metal battery 蜂巢能源科技股份有限公司 2024-10-01 CN claimed
US-20230380457-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-30 US claimed
EP-4280882-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2023-11-29 EP claimed
US-20230363426-A1 Materials and Methods for Extending Shelf-Life of Foods JP LABORATORIES, INC. 2023-11-16 US claimed
CN-116916755-A Materials and methods for extending the shelf life of food products JP实验室公司 2023-10-20 CN claimed
CN-106045938-A Synthesis method of dehydroabietic-acid-based B ring-fused-thiazole-thiocarbamide compounds 广西大学 2016-10-26 CN claimed
US-20160250175-A1 COMBINED APPLICATION OF ISOTHIOCYANATE COMPOUND AND ANTI-CANCER MEDICINE JC (WUXI) COMPANY, INC. (CN) 2016-09-01 US claimed
EP-3034076-A1 COMBINED APPLICATION OF ISOTHIOCYANATE COMPOUND AND ANTI-CANCER MEDICINE JC (Wuxi) COMPANY, Inc. (CN) 2016-06-22 EP claimed
CN-103992265-B Two three bromo 1,3-bis-pyridine alkali propane and preparation method thereof, using method, recovery method and application XI'AN JIAOTONG UNIVERSITY (CN) 2016-02-24 CN claimed
CN-103864655-B A kind of synthetic method of dehydrogenation abietyl thiourea derivative GUANGXI UNIVERSITY (CN) 2015-12-30 CN claimed
CN-103992265-A Double tribromo 1,3-bipyridine onium salt dimethylmethane, and preparation method, application method, recovery method and application thereof UNIV XI AN JIAOTONG 2014-08-20 CN claimed
CN-103864655-A Synthetic method of dehydroabietic acid group thiourea derivative UNIV GUANGXI 2014-06-18 CN claimed
WO-2010065329-A2 NANOPARTICLES FOR CANCER TREATMENT THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2010-06-10 WO claimed
US-20060241178-A1 Compositions and methods for treating lung cancer IMMUNEGUARD LLC (US) 2006-10-26 US claimed
WO-2004060365-A1 COMPOSITIONS AND METHODS FOR TREATING LUNG CANCER AMERICAN HEALTH FOUNDATION (US) 2004-07-22 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160250175-A1 COMBINED APPLICATION OF ISOTHIOCYANATE COMPOUND AND ANTI-CANCER MEDICINE CHUK, KIT, MKI67 ALDH1A1 2081/4885CYP3A4 2452/4885HPGD 3624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.